We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioVendor Group

BioVendor Group is an international group of biotechnology companies (BioVendor LM, BioVendor R&D, TestLine, ViennaLa... read more Featured Products: More products

Download Mobile App





BioVendor Group Introduces Groundbreaking Immunological Biomarker

By LabMedica International staff writers
Posted on 13 Nov 2024

At this year’s MEDICA, BioVendor Group (Brno, Czech Republic) is showcasing its impressive diagnostic innovations, from CLIA advancements to the groundbreaking MxA biomarker, which plays a key role in distinguishing between bacterial and viral infections. More...

BioVendor Group is fitting all group companies into a shared exhibition space at MEDICA 2024 and creating a welcoming environment for hundreds of meetings with new and existing business partners, customers, and suppliers. Visitors to the shared BioVendor Group booth can learn about several other product news and innovations from the companies BioVendor Research & Diagnostic Products, TestLine Clinical Diagnostics s.r.o., ViennaLab Diagnostics, DIAsource ImmunoAssays S.A. and BioVendor MDx. The main "drivers" are again the key projects CLIA, MBA, and NGS, developed in synergy by the various companies of the BioVendor Group. BioVendor is introducing brand-new micro-array kits from TestLine Clinical Diagnostics for the diagnosis of liver and gastrointestinal autoimmune diseases. Also featuring at the show is BioVendor MDx’s NGS fastGEN technology which offers rapid and accurate genetic analysis, enabling efficient cancer diagnostics. BioVendor MDx’s fastGEN BCR::ABL1 cancer kit specifically detects fusion genes associated with leukemia, supporting early diagnosis and treatment management. In addition to these innovations, visitors can also learn more about BioVendor MDx’s bioinformatics solution GENOVESA which is designed for seamless data interpretation and reporting.

DIAsource is announcing the addition of a new rapid test (POCT) and its respective reader to the company’s portfolio. These products complete the company’s panel with additional technologies and interesting parameters in the fields of women’s health, tumor markers, drugs of abuse, infectious diseases, cardiac markers. DIAsource is also launching a series of new antibodies in the fields of Alzheimer's disease, cardiac markers, diabetes and fertility. These antibodies have proven to be reliable raw materials in the manufacturing of immunoassays such as CLIA, ELISA, FIA, and POCT. BioVendor RnD is showcasing its extensive portfolio of ELISA kits for both research and diagnostic applications. In addition to its high-quality ELISA kits, the company is highlighting its high-purity proteins and a broad range of antibodies. BioVendor RnD is also presenting the MxA Point-of-Care-Test designed for the rapid differentiation between bacterial and viral infections. Visitors to the shared BioVendor Group booth can also learn about ViennaLab’s upcoming SMA RealFast Assay, comprehensive OncNGS (liquid biopsy (cfDNA) NGS solution), 16S Microbiome + ITS NGS Assay.

Related Links:
BioVendor Group 


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.